Genotyping is an important component of measles surveillance. In this study, we report the genotypes of 30 measles viruses from cases in Canada; 6 of these were collected between 1979 and 1996 and 24 were collected from 1997 through 2002. Many measles virus genotypes were found (C1, C2, D3, D4, D5, D6, D7, D8, E, and H1). These data indicate that the predominant measles virus genotypes detected from 1979 to 1997 in Canada are no longer commonly found. Since the implementation of a routine second dose of measles vaccine and catch-up campaigns in 1996-1997, the wide variety of measles virus genotypes found supports epidemiological data showing that importation of measles is the source of current measles cases in Canada.
In 1996-1997, routine second doses and catch-up measles vaccination campaigns were introduced in Canada [1] . At the same time, enhanced surveillance of measles was implemented. The laboratory aspects of measles surveillance include serological confirmation of all suspected measles cases as well as measles virus strain identification by genotyping [2] . Genotyping of measles virus is important for mapping transmission routes, documenting the elimination of endemic virus strains, and differentiating vaccine from wild-type strains. Molecular epidemiological studies published recently have greatly improved the understanding of the distribution of measles virus strains in various regions of the world [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . However, continued sampling of measles virus strains is needed for a more complete understanding of their evolving global distribution.
Measles virus genotyping is based on analysis of the genetic variability in the carboxyl-terminal coding region of the nucleoprotein (N) gene and/or in the entire hemagglutinin (H) gene. The genotyping strategy and nomenclature for wild-type measles viruses have been standardized by the World Health Organization [13, 14] . We report here the genotypic analysis of wild-type measles viruses in Canada from 1979 through 2002.
MATERIALS AND METHODS

Clinical specimens and measles virus isolation.
Specimen collection and measles virus isolation were done according to standard procedures [2] . Urine, nasopharyngeal swabs, or throat swabs were collected within 7 days after onset of rash from clinical measles case patients. The Epstein-Barr virus-transformed lymphoblastoid cell line, B95-a, was used for the isolation of most of the strains reported here. Vero cells were used for the pre-1990 measles virus isolations in Montreal. Isolates were passaged a maximum of 2 times before sequence analysis. Virus isolations were done by hospital laboratories and provincial public health laboratories across Canada. In cases in which measles virus isolation was unsuccessful or not attempted, clinical specimens were analyzed directly by reverse transcriptase-polymerase chain reaction (RT-PCR) for the presence of measles virus RNA. Both virus isolates and clinical specimens were sent to the National Microbiology Laboratory for genotypic analysis.
RT-PCR amplification. Total RNA was extracted from measles isolates (infected tissue culture cells) or directly from clinical specimens by use of Tri-Reagent LS (Sigma) or RNeasy Mini Kit (Qiagen). RT-PCR was done with SuperScript II reverse transcriptase (Gibco Life Technologies) and Platinum Taq DNA polymerase (Gibco Life Technologies). The carboxyl-terminal coding region of the N gene was amplified with primers MVN1109 (5 -GCTATGC-CATGGGAGTAGGAGTGG-3 ) and MVN1698R (5 -GGCCT-CTCGCACCTAGTCTAGTCTAG-3 ). The H gene was amplified with primers MVH7271 (5 -ATGTCACCACAACGAG-ACC-3 ) and MVH9172R (5 -GTATGCCTGATGTCTGGGT-GAC-3 ).
Nucleotide sequence analysis. Before sequencing, PCR amplicons were purified with the QIAquick PCR Purification Kit (Qiagen). DNA sequencing was done with an ABI 377 DNA Sequencer and the BigDye Terminator Cycle Sequencing System (PE Biosystems). Both sense and anti-sense DNA strands were sequenced.
Sequence data were analyzed with version 10.0 of the Genetics Computer Group Sequence Analysis Software Package [15] , and phylogenetic analyses used maximum parsimony [16] . All phenograms were drawn as unrooted trees. Bootstrap support levels (i.e., percentage of resampled replicates in which the marked cluster appears) were calculated on the basis of 100 replicates [17] . The carboxyl-terminal-coding 456 nucleotides of the N gene and the entire 1855-nucleotide H gene were used for the sequence alignments.
Measles virus reference strains were designated by the World Health Organization [13, 14] . The sequences reported here have been deposited into GenBank under accession numbers AF410972-AF411005, AF427163-AF427168, and AY160180-AY160183.
RESULTS
The National Microbiology Laboratory has analyzed 170 measles virus strains collected in Canada. In this study, however, multiple isolates from the same outbreak and postvaccination genotype A strains have been excluded. The genotypes of 30 measles viruses are discussed here. Genotypic designations and phylogenetic trees of selected wild-type measles viruses are shown in table 1 and figure 1, respectively. The N gene and H gene alignments show identical clustering (figure 1).
Measles virus strains in Canada, 1979-1996. Genotype information on measles viruses in Canada before 1997 was limited. Only 3 strains were identified before 1989, a C1 strain in 1979, a C2 strain 1984, and a rare E strain in 1987. These strains were obtained from patients at the Montreal Children's Hospital. There was no epidemiological information about these cases other than Montreal-84 [C2] being isolated from a patient who acquired measles through exposure in the hospital.
A 1989 provincewide measles outbreak in Québec was the source of at least 8 genotype D4 isolates from Montreal, 2 of which are reported here (Montreal-12-89 and Montreal-25-89), as well as the D4 reference strain Montreal.CAN-89 [18] . All these D4 viruses were identical in their N gene sequences. The outbreak began in Montreal in December 1988 and lasted until September 1989, resulting in 10,184 cases in Québec. The original source of the outbreak was not known.
In 1996, a D5 strain was obtained from a sporadic case in Toronto; the patient had recently traveled to South Carolina. However, there were no reported measles cases in South Carolina at that time.
Measles virus strains in Canada, 1997-2002. Several measles outbreaks occurred in Canada in 1997, resulting in a total of 581 cases. The first outbreak began in Vancouver in January 1997 and spread to several regions in Alberta after a sports tournament in Calgary [19] [20] [21] . Eleven viruses were genotyped from these outbreaks, 4 of which are reported here. Measles viruses from these epidemiologically linked outbreaks (from Vancouver, Calgary, and Edmonton) were all determined to be genotype D6. The original source of the Vancouver outbreak was not known. Another D6 strain was obtained in March 1997 from an outbreak of 8 measles cases in Newfoundland that was epidemiologically linked with an index case patient who had recently traveled to Florida [21] . In May 1997, a C2 strain was isolated from an outbreak of 13 Calgary measles cases epidemiologically linked with an index case patient who had recently traveled to Germany (Calgary Regional Health Authority, Calgary, Canada, personal communication, 1998).
Measles viruses from sporadic cases have also been genotyped. Imported cases (defined as a case in someone who had traveled outside Canada 7-21 days before onset of rash) from France (C2 strain) in July 1997 and from Japan (D3 strain) in May 1999 were detected in Montreal and Halifax, respectively. A D8 strain was detected in May 1998 in a Montreal case patient having neither a known epidemiological link nor recent travel history.
Measles viruses from several outbreaks in Canada in 1999-2000 have been genotyped. These outbreaks are described by King et al. [1] in this supplement. In October-November 1999 in Alberta, an outbreak involving 17 cases resulted from an importation of a D6 strain from The Netherlands, where a large outbreak occurred in 1999 [22] . In March-May 2000, an outbreak of 6 cases in Alberta was determined to be a D7 strain. measles cases in Toronto in January-February 2001 were also due to an H1 strain virus; the original source of these Toronto cases was not known. The N gene sequences of the Halifax, Vancouver, and Toronto H1 measles viruses were all identical to one another and to measles viruses from Illinois and Washington. Similar to the Halifax and Vancouver cases, both of the US cases were importations from Korea [9] . In February-March 2001, another importation of an H1 strain, this time from Singapore, resulted in 3 measles cases in Hamilton, Canada.
The Singapore H1 strain differed from the Korea H1 strain at 3 nucleotide positions. Two separate D5 measles virus importations to Calgary occurred in 2001. In May, a D5 virus was imported from Germany, resulting in 3 cases. In September, a D5 measles virus was detected from a cluster of cases that were epidemiologically linked with importation from New Zealand.
In 2001, 2 separate measles cases in Vancouver were determined to be due to D5 and D3 viruses, but the sources of these cases were not known. In February 2002, a child from India traveled via Edmonton to Winnipeg, where measles was serologically confirmed in the child. Two cases due to genotype D4 were detected in Edmonton, corresponding to exposure to the putative index case in Winnipeg.
DISCUSSION
The epidemiology of measles in Canada for the years 1979-2002 is discussed in several publications [1, [18] [19] [20] [21] [22] [23] [24] [25] [26] . In brief, there were measles epidemics in Canada in 1979 (22,444 cases), 1986 (15,136 cases), 1989 (11,148 cases), 1991 (6178 cases), 1992 (3011 cases), and 1995 (2362 cases). Unfortunately, there are large gaps in the information on the distribution of measles virus genotypes in Canada before the implementation of enhanced measles surveillance in 1997. The endemic measles virus strains circulating in Canada are not known before 1989 nor for the years 1990-1996.
However, a few measles viruses from these time periods were genotyped. The most interesting was an E strain measles virus from 1987, which is the only reported genotype E aside from the Braxator reference strain. The Braxator strain was isolated in Germany in 1971 and is no longer thought to be circulating [13] .
An exception to this gap in knowledge prior to 1997 is the genotyping information from 1989. A provincewide measles outbreak in Québec occurred in 1989, accounting for 91% of the 11,148 measles cases in Canada in 1989 [18] . The measles viruses from this outbreak were collected over the time span of the outbreak and are all identical genotype D4 viruses. It is therefore reasonable to consider that genotype D4 was the predominant measles virus strain circulating in Canada in 1989. Interestingly, the D4 strain circulating in Canada in 1989 is different from the D3 strain responsible for the large resurgence of measles in the United States from 1989 to 1991 (155,000 cases) [3] .
Measles virus genotyping data have been routinely collected in Canada since 1997, when it became a component of the measles enhanced surveillance program. Consequently, representative isolates were obtained from measles outbreaks in 1997, which occurred initially in British Columbia and spread into Alberta [19, 20] . The consistent finding of the D6 strain from different locations over the course of these outbreaks confirmed the epidemiological link between these outbreaks. These outbreaks were responsible for 190% of the 581 measles cases in Canada in 1997. It is therefore reasonable to consider genotype D6 as the endemic strain in Canada in 1997.
Genotype D6 was responsible for the 1997 Brazil outbreak that subsequently spread into other South American countries and was the predominant strain in South America for several years [26, 27] . Importation of genotype D6 virus from Bolivia into Alberta resulted in an outbreak of 155 cases in 2000 [21] ; interestingly, this D6 measles virus was identical in sequence to a 1997 D6 virus from Rio de Janeiro, confirming the high stability of the measles virus genome over time [27] .
Molecular epidemiological information was used to distinguish independent outbreaks occurring relatively close in time in the same location. The detection of a C2 strain from a Calgary measles outbreak in 1997 confirmed this small outbreak to be distinct from the larger outbreak due to strain D6 in British Columbia and Alberta. Similarly, in 2001, concurrent measles cases in Toronto and Hamilton (closely situated geographically) were both due to genotype H1 viruses. However, these H1 viruses differed at 3 nucleotides and thus were distinct viruses, confirming the Toronto and Hamilton cases to be unrelated [1] .
A variety of genotypes have been found in Canada from 1997 to 2002. This is similar to what has been seen in the United States in recent years [3, 9] . The variety of genotypes resulting from importation of measles virus typically reflects the measles virus strain(s) circulating in the country of origin. The imported D3 strain from Japan corresponds with published reports finding genotype D3 measles virus to be a predominant Japanese genotype [7, 14] . Genotype C2 and D6 viruses have been imported from France, Germany, Belgium, and The Netherlands, confirming C2 and D6 to be common European genotypes [6, 14, 28] . Similarly, the finding of genotype H1 viruses imported from Korea and Singapore confirms the presence of the H1 strain in Asia [14] . Two separate importations of genotype D5 from Germany and New Zealand occurred in 2001, adding to our understanding of the global distribution of this genotype; D5 has previously been reported in Japan, Namibia, and Thailand [14] . The 2 Edmonton cases due to D4 genotype in 2002 are almost certainly linked with the confirmed Winnipeg index case patient's recent travel history to India and then Edmonton; the exposure and incubation time corresponds, and genotype D4 viruses have been commonly found in India [9, 14] .
Last, 2 measles viruses reported here belong to recently designated genotypes in the D clade, the D7 strain from a 2000 importation from Mexico and the D8 strain from a 1998 Montreal measles case. The D7 measles virus strain has previously been found in Australia, Germany, and Spain, and the D8 strain has previously been found in Ethiopia, India, and Nepal [8, 10, 14] . It should be noted for the D7 importation that an active search in Mazatlan, Mexico, did not reveal any other cases of measles, indicating that the original source of the D7 strain was likely somewhere other than Mexico. This case illustrates the often difficult task of tracking virus transmission pathways in situations such as resorts and airports, in which many people are coming from and going to many places.
In summary, we have seen a shift in the endemic measles virus strain in Canada from D4 in 1989 to D6 in 1997. However, since 1997, sustained transmission of strain D6 in Canada has not been shown despite intensive enhanced surveillance efforts. All recent D6 isolates have been confirmed to be imported cases without sustained transmission. The variety of genotypes currently found in Canada reflects importation of measles virus from different regions of the world. Continued importation of measles virus into Canada will continue to be a reality until global measles eradication is achieved [29] . It is important to continue molecular epidemiological surveillance of measles virus in Canada to monitor our measles elimination program, and to collect genotyping data from all regions of the world to better understand the global distribution of measles virus strains.
